Drug Price Trends for CYCLOBENZAPRINE ER

Average Pharmacy Cost for CYCLOBENZAPRINE ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
CYCLOBENZAPRINE ER 15 MG CAP	00115-1436-13	1.19479	EACH	2025-03-19
CYCLOBENZAPRINE ER 15 MG CAP	24979-0035-04	1.19479	EACH	2025-03-19
CYCLOBENZAPRINE ER 15 MG CAP	00093-1920-06	1.19479	EACH	2025-03-19
CYCLOBENZAPRINE ER 15 MG CAP	00093-1920-06	1.37175	EACH	2025-02-19
CYCLOBENZAPRINE ER 30 MG CAP	24979-0036-04	2.76206	EACH	2025-02-19
CYCLOBENZAPRINE ER 15 MG CAP	24979-0035-04	1.37175	EACH	2025-02-19

Market Analysis and Price Projections for Cyclobenzaprine ER

Overview of Cyclobenzaprine ER

Cyclobenzaprine is a skeletal muscle relaxant commonly used to treat muscle spasms caused by acute, painful musculoskeletal conditions. It operates by reducing the release of certain molecules that induce muscular discomfort and swelling, thereby relaxing muscles and reducing pain[1][2].

Market Growth and Trends

The global cyclobenzaprine market is anticipated to experience significant growth, driven primarily by the high prevalence of chronic pain conditions such as low back pain, osteoarthritis, and fibromyalgia. According to the US Department of Health & Human Services, approximately 20.4% of adults suffer from chronic pain, with 7.4% experiencing high-impact chronic pain that frequently limits life or work activities[1].

CAGR and Market Size

The global cyclobenzaprine market is expected to grow at a CAGR of 4.2% during the forecast period. This growth is attributed to the increasing demand for effective treatments for chronic pain and muscle spasms[1].

Regional Outlook

The Asia-Pacific region is projected to hold a significant share in the global cyclobenzaprine market, followed by North America and Europe. The growth in the Asia-Pacific region can be attributed to the expanding geriatric population, rising disposable income, and increasing healthcare expenditure in countries like India and China[1].

Market Segmentation

By Application

The relieve muscle spasms segment holds a prominent share in the global cyclobenzaprine market. Cyclobenzaprine is widely used to treat muscle spasms caused by acute, painful musculoskeletal problems, making this segment a key driver of market growth[1].

By Product Type

Cyclobenzaprine is available in various forms, including oral tablets and extended-release capsules. The extended-release capsules, such as those under the brand name Amrix, are particularly popular for their convenience and efficacy in managing chronic pain[2][5].

Pricing and Cost Analysis

Cyclobenzaprine ER Prices

The prices for cyclobenzaprine ER vary based on the dosage and quantity. Here are some examples:

• 15 mg Oral Capsule, Extended Release: Prices start from around $175.42 for 30 capsules, with the cost per unit decreasing as the quantity increases[2][5].
• 30 mg Oral Capsule, Extended Release: Similarly, prices start from around $175.42 for 30 capsules, with similar pricing structures as the 15 mg capsules[2][5].

Brand Name vs Generic

The brand name version, Amrix, is significantly more expensive than the generic version. For instance, Amrix 15 mg oral capsule, extended release, can cost around $3,676 for a supply of 60 capsules, while the generic version costs substantially less[5].

Market Drivers and Opportunities

Increasing Prevalence of Chronic Pain

The rising prevalence of chronic pain conditions is a major driver of the cyclobenzaprine market. As the global population ages and the incidence of conditions like arthritis and fibromyalgia increases, the demand for effective pain management solutions like cyclobenzaprine is expected to grow[1].

Advancements in Healthcare

Continuous advancements in healthcare, including better diagnostic tools and treatment options, are also driving the market. Increased healthcare expenditure in many regions, particularly in the Asia-Pacific, is further boosting market growth[1].

Market Restraints and Challenges

Side Effects and Safety Concerns

Cyclobenzaprine can have side effects such as drowsiness, dizziness, and dry mouth, which can be a restraint for some patients. Additionally, safety concerns, especially in older adults, can limit its use in certain cases[2].

Regulatory Environment

Stringent regulatory requirements and the need for continuous monitoring of drug safety can also pose challenges to market growth. Manufacturers must comply with various regulations, which can be time-consuming and costly[4].

Competitive Landscape

The global cyclobenzaprine market is competitive, with several key players offering both brand name and generic versions of the drug. The market is characterized by intense competition, with companies focusing on pricing strategies, product innovation, and patient assistance programs to gain market share[1][4].

Impact of COVID-19

The COVID-19 pandemic had a mixed impact on the cyclobenzaprine market. While there was an initial disruption in supply chains and healthcare services, the pandemic also highlighted the importance of effective pain management, leading to increased demand for drugs like cyclobenzaprine. The recovery scenario post-pandemic is expected to be positive, with the market returning to its growth trajectory[1].

Key Takeaways

• The global cyclobenzaprine market is expected to grow at a CAGR of 4.2% driven by the increasing prevalence of chronic pain.
• The Asia-Pacific region is anticipated to hold a significant share in the market.
• The relieve muscle spasms segment is the most prominent application segment.
• Pricing varies significantly between brand name and generic versions.
• Market growth is driven by increasing healthcare expenditure and the aging population.

FAQs

What is the primary use of cyclobenzaprine ER?

Cyclobenzaprine ER is primarily used to treat muscle spasms caused by acute, painful musculoskeletal conditions.

Which region is expected to dominate the global cyclobenzaprine market?

The Asia-Pacific region is expected to dominate the global cyclobenzaprine market due to the expanding geriatric population and increasing healthcare expenditure.

What is the difference in pricing between brand name and generic cyclobenzaprine ER?

The brand name version, Amrix, is significantly more expensive than the generic version. For example, Amrix 15 mg oral capsule, extended release, can cost around $3,676 for 60 capsules, while the generic version costs substantially less.

What are the major drivers of the cyclobenzaprine market?

The major drivers include the increasing prevalence of chronic pain conditions, advancements in healthcare, and rising healthcare expenditure.

What are the potential side effects of cyclobenzaprine ER?

Potential side effects include drowsiness, dizziness, and dry mouth, which can be a restraint for some patients.

Sources

1. OMR Global: Cyclobenzaprine Market Share, Trends, Growth | Analysis and Forecast.
2. Drugs.com: Cyclobenzaprine Prices, Coupons, Copay Cards & Patient Assistance.
3. Market Research Intellect: Global cyclobenzaprine drug market size and forecast 2.
4. Cognitive Market Research: Cyclobenzaprine Drug Market Report 2024 (Global Edition).
5. Drugs.com: Amrix Prices, Coupons, Copay Cards & Patient Assistance.